- Research works
- 57 ▲ 69% vs 2013–17
- Citations
- 1.1k 18.9 per fractional work
- Top-10% rate
- 20.6% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: Biogen (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.7×. Every wedge is a field page.
Which keywords describe research at Biogen (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Diagnostic Criteria, Cognitive Impairment, Multiple Sclerosis, Neuromyelitis Optica, Monoclonal Antibodies, Quality of Life, Clinical Outcomes and Biopharmaceuticals.
- Polyomavirus
- Teratogenicity
- Pregnancy
- Childhood Cancer
- Pediatric Pharmacokinetics
- Rheumatoid Arthritis
- Neurodegeneration
- Drug Development
- Idiopathic Pulmonary Fibrosis
- Genetics
- Diagnosis
- Treatment
- Spinal Muscular Atrophy
- Fibrosis
- Health Utility Measures
- Clinical Outcomes
- Biopharmaceuticals
- Quality of Life
- Neuromyelitis Optica
- Cognitive Impairment
- Diagnostic Criteria
- Multiple Sclerosis
- Monoclonal Antibodies
- Bioanalytical Methods
- Biosimilars
- Cost-effectiveness Analysis
- Immunogenicity
- SMN1
- Autoantibodies
- Clinical Trials
- Prognostic Factors
- TGF-ß
- Interstitial Lung Disease
- Inflammatory Bowel Disease
- Lymphoma
- Off-Label Drug Use
- Acute Lymphoblastic Leukemia
- Minimal Residual Disease
- Renal Transplantation
- Merkel Cell Carcinoma
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Diagnostic Criteria5▲ 43×3 topics
- Cognitive Impairment5▲ 37×2 topics
- Multiple Sclerosis5▲ 253×1 topic
- Neuromyelitis Optica5▲ 253×1 topic
- Monoclonal Antibodies4▲ 52×3 topics
- Quality of Life4▲ 5.4×6 topics
- Bioanalytical Methods3▲ 385×1 topic
- Biopharmaceuticals3▲ 86×2 topics
- Biosimilars3▲ 385×1 topic
- Clinical Outcomes3▲ 29×2 topics
- Cost-effectiveness Analysis3▲ 75×1 topic
- Health Utility Measures3▲ 75×1 topic
- Immunogenicity3▲ 114×2 topics
- Fibrosis3▲ 24×4 topics
- SMN13▲ 201×1 topic
- Spinal Muscular Atrophy3▲ 201×1 topic
- Autoantibodies2▲ 19×4 topics
- Treatment2▲ 3.0×5 topics
- Clinical Trials2▲ 6.0×6 topics
- Diagnosis2▲ 3.5×6 topics
- Prognostic Factors2▲ 7.9×3 topics
- Genetics2▲ 4.0×3 topics
- TGF-ß2▲ 19×4 topics
- Idiopathic Pulmonary Fibrosis2▲ 78×1 topic
- Interstitial Lung Disease2▲ 56×1 topic
- Drug Development2▲ 20×2 topics
- Inflammatory Bowel Disease2▲ 26×3 topics
- Neurodegeneration2▲ 9.3×4 topics
- Lymphoma2▲ 18×3 topics
- Rheumatoid Arthritis2▲ 27×2 topics
- Off-Label Drug Use1▲ 65×1 topic
- Pediatric Pharmacokinetics1▲ 65×1 topic
- Acute Lymphoblastic Leukemia1▲ 62×1 topic
- Childhood Cancer1▲ 62×1 topic
- Minimal Residual Disease1▲ 35×2 topics
- Pregnancy1▲ 11×3 topics
- Renal Transplantation1▲ 43×2 topics
- Teratogenicity1▲ 35×2 topics
- Merkel Cell Carcinoma1▲ 104×1 topic
- Polyomavirus1▲ 104×1 topic
Which research topics does Biogen (United Kingdom) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Biosimilars and Bioanalytical Methods, Neurogenetic and Muscular Disorders Research and Multiple Sclerosis Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 2 Biosimilars and Bioanalytical Methods Immunology 1 works
- 3 Neurogenetic and Muscular Disorders Research Genetics 1 works
- 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 1 works
- 5 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 6 Urticaria and Related Conditions Rheumatology 0 works
- 7 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 8 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 9 Hematological disorders and diagnostics Emergency Medicine 0 works
- 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biogen (United Kingdom)'s research output changed?
Output in 2018–2022 was 69% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Maidenhead
- Abbott (United Kingdom)
- Berkshire College of Agriculture
- Institute of Clinical Research
- Huntercombe Hospital
- Costain (United Kingdom)
- AbbVie (United Kingdom)
- NSK (United Kingdom)
- Zogenix (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.